Position in MGTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,012,953
+$4,760,653 QoQ
Shares Held
3,465,699
+9.1% QoQ
Ownership
3.74%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MGTX Over Time
Shares Held
Position Value (USD)
Derivatives in MGTX
reported options exposure · as of Sep 30, 2025CallValue
$92,999
CallShares
11,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names. MGTX ranks #37 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in MGTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,012,953 | 3,465,699 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,252,300 | 3,176,390 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,076,774 | 2,560,969 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $92,999 | 11,300 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $5,119,380 | 785,181 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $297,526 | 48,855 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $377,643 | 90,562 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $262,636 | 62,384 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,764,973 | 290,770 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $947,524 | 134,975 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $201,149 | 29,933 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $158,915 | 30,738 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $73,773 | 11,315 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $492,363 | 58,545 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $744,040 | 98,288 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,157,956 | 83,607 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | $578,253 | 40,073 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,397,164 | 92,283 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $159,304 | 12,724 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||